Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060413) titled 'Biopsychosocial factors associated with treatment decision-making for anti-amyloid beta antibody therapy in early Alzheimer's disease: a multicenter prospective observational study' on Jan. 20.
Study Type:
Observational
Primary Sponsor:
Institute - St. Marianna University School of Medicine
Condition:
Condition - Early Alzheimer's disease (MCI due to AD / mild AD dementia)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify biopsychosocial factors associated with treatment decision-making in patients initiating anti-amyloid beta antibody therapy (lecanemab ...